| CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis | |
| Jin, Lei; Liu, Wei-Ren; Tian, Meng-Xin; Jiang, Xi-Fei; Wang, Han; Zhou, Pei-Yun; Ding, Zhen-Bin; Peng, Yuan-Fei; Dai, Zhi; Qiu, Shuang-Jian | |
| 刊名 | ONCOTARGET
 |
| 2017 | |
| 卷号 | 8期号:3 |
| 关键词 | CCL24 HCC RhoB VEGFA prognosis |
| ISSN号 | 1949-2553 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3619036 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Jin, Lei,Liu, Wei-Ren,Tian, Meng-Xin,et al. CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis[J]. ONCOTARGET,2017,8(3). |
| APA | Jin, Lei.,Liu, Wei-Ren.,Tian, Meng-Xin.,Jiang, Xi-Fei.,Wang, Han.,...&Shi, Ying-Hong.(2017).CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis.ONCOTARGET,8(3). |
| MLA | Jin, Lei,et al."CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis".ONCOTARGET 8.3(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论